Brazil
Every company in the roster headquartered in Brazil.
Every company in the roster headquartered in Brazil.
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Eurofarma LaboratoriosPrivate | 3 assets: 1 approved, 2 Ph 3 | EvogliptinPhase 3 · Type 2 DiabetesReliable signal | 31 Jan 2027Cenobamate · Phase 2 | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.